Interestingly, IVIG treatment was shown to suppress autoimmunity through IL-33 induced TH2 responses (Anthony et al., 2011), suggesting that IL-33/ST2 pathway may activate anti-inflammatory mechanisms in other settings. Here, IL33 is linked to Autoimmunity.